Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for TD and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for TD and 80,000+ other tickers.
See exactly how TD's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TD and 80,000+ other tickers.
The Toronto-Dominion Bank, along with its affiliated entities, delivers a comprehensive array of financial solutions and services across Canada, the United States, and various international markets. Its operations are structured into three primary divisions: Canadian Retail, U.S. Retail, and Wholesale Banking. For individual customers, the bank provides fundamental deposit products like checking, savings, and investment accounts. Businesses can access a suite of offerings including funding, investment management, cash flow solutions, international trade facilities, and everyday banking…
The Toronto-Dominion Bank (TSE: TD - Get Free Report) (NYSE: TD) has received an average recommendation of "Moderate Buy" from the eleven research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and seven have assigned a buy recommendation to
Investors interested in Banks - Foreign stocks are likely familiar with UBS (UBS) and Toronto-Dominion Bank (TD). But which of these two companies is the best option for those looking for undervalued stocks?
This biotech stock could soar 30% or more over the next 12 months if some analysts are right.
Toronto-Dominion Bank (TSX:TD) plans to buy back up to $10 billion worth of its shares in a new program expected to wrap up by July 2027. The bank will repurchase up to 61 million shares, representing up to 3.74% of its nearly 1.63 million common shares issued and outstanding as of August 31.
Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsKen Griffin donates $3B to Carnegie Mellon: Citadel CEO Ken Griffin p